Bryan Sheehan, DPM
Podiatrist · Grove, OKNPI 1427031863
Payments from drug & device makers
What this record shows
This record is dominated by education: $4,503 of the $5,172 with a category attached, or 87.1%. Elite Orthopedics, LLC accounts for 61.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $4,129 and has fallen 93.9% since, to $251 in 2025.
Across 39 payments — averaging $132.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elite Orthopedics, LLC$3K
- Pylant Medical$972
- Organogenesis Inc.$322
- DJO, LLC$216
- Rikco International, LLC$158
- Amgen$117
- plus $231 from 8 others
What the payments were for
- Food & beverage$66913%
- Education$4,50387%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elite Orthopedics, LLC | 1 | $3,157 |
| Pylant Medical | 1 | $972 |
| Organogenesis Inc. | 20 | $322 |
| DJO, LLC | 3 | $216 |
| Rikco International, LLC | 2 | $158 |
| Amgen | 1 | $117 |
| Nabriva Therapeutics, PLC | 3 | $58 |
| Dynasplint Systems Inc. | 1 | $44 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| Globus Medical | 1 | $29 |
| Boston Scientific | 1 | $18 |
| Bioventus LLC | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Polynovo North America LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$117
- DR COMFORT$104
How this compares
$5,172 in reported general payments places this provider in the 80th percentile of 54 podiatrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 97 | $1,044 |
| Clindamycin Hcl | 75 | $871 |
| Celecoxib | 50 | $582 |
| Ciprofloxacin Hcl | 40 | $454 |
| Diclofenac Potassium | 17 | $408 |
| Nystatin | 29 | $341 |
| Ondansetron Hcl | 31 | $245 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $152 |
| Triamcinolone Acetonide | 27 | $128 |
| Tramadol Hcl | 35 | $107 |
| Amoxicillin | 11 | $71 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Grove
- Megan MartinGrove$3K
- David CavallaroOklahoma City$22K
- Ahmed BukshEdmond$17K
- Aerial AveryAda$13K
- Patricia BoehleOklahoma City$10K
- Kevin DuxMuskogee$8K
- Barinder BassiTahlequah$7K
- Greg RohdeNorman$7K
- Thomas WicksChickasha$6K
- Tera SantistevanSapulpa$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.